Chronic pain expert and leading UK medical cannabis prescriber, Dr Sunny Nayee, has joined Akanda to focus on improving patient care.
International medical cannabis company, Akanda, has named chronic pain expert and experienced cannabis prescriber, Dr Sunny Nayee as its new UK medical director.
The appointment of Dr Nayee builds upon the company’s recent partnership with Cellen – the health tech company behind one of the UK’s first fully-digital pain clinics – in a bid to expand patient access to cannabis medicines.
In his role with Akanda, Dr Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.
Dr Nayee has been prescribing cannabis since 2019, and currently treats in excess of 1,000 patients.
He holds prizes from the NHS Strategic Health Authority’s innovation committee and Royal College of General Practitioners for work related to patient safety and has published research reviewing the safety and effectiveness of medical cannabis treatment for the treatment of chronic refractory pain.
He joins Akanda from the Lyphe Group, where he served as medical director.
Dr Nayee commented: “My focus has always been on accurately diagnosing patients then giving them access to the best treatment options available.
“I’m excited to join up with Akanda and Cellen to play a fundamental role in helping to democratise access to medical cannabis for patients in need.”
Dr Nayee will be working closely with Cellen to enable Akanda to better address unmet healthcare needs of patients globally, starting with the UK.
Akanda recently signed a Memorandum of Understanding with the company, which will see the two work together to optimise medical cannabis supply chain activities across Cellen and Akanda business interests, to increase supply and choice for patients in the UK.
“It is an honour to welcome Dr Nayee to the Akanda team as we build the first seed-to-patient model, serving medical cannabis patients in the UK and Europe,” commented Tej Virk, Akanda’s CEO.
“Dr. Nayee is a renowned pain treatment expert with direct experience in cannabis therapies. This makes him the ideal face of Akanda for patients. I’m looking forward to having Dr Nayee by our side as we build a patient-oriented supply chain in the UK and eventually other international markets.”
For more industry news visit Cannabis Wealth
- Four new medical cannabis studies to catch-up on
- Are CBD gummies worth the hype?
- CBD delivery method approaches 100% bioavailability in dogs
- Ukraine’s battle for medical cannabis – the campaigners on the frontline
- How to mitigate the side effects of cannabis
- Watch: families for medical cannabis – Mitchell and Caroline
- Beauty & Skincare2 months ago
How long does it take for a hemp bath to work?
- News5 months ago
40 inspirational women in cannabis
- Science5 months ago
Can CBD help with excessive sweating?
- Sleep4 weeks ago
How to get a good night’s sleep in the hot weather
- News6 months ago
Project Twenty21 prices to remain the same next month as talks ongoing
- Fibromyalgia5 months ago
UK trial of cannabinoids as treatment for fibromyalgia expected this year
- News1 month ago
MHRA confirms supply of medical cannabis product until 2023
- Advocacy2 months ago
Can I travel abroad with my medical cannabis prescription?